ABT compared with JNJ: revenue, margins and what each company keeps, and the suppliers and customers both name

ABTAbbott Laboratories

Mkt capRevenueRevenue

JNJJohnson & Johnson

Mkt capRevenueRevenue

Compare

ABTAbbott Laboratories

JNJJohnson & Johnson

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ABT

3 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 21 '26±5.3%▼−1.89%×0.36

Q2 FY26±4.3%▲+10.71%×2.49

Q1 FY26±4.4%▼−6.00%×1.36

Jan 22 '26±3.2%▼−10.04%×3.13

JNJ

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.1%▼−5.73%×1.84

Q2 FY26±2.9%▼−2.69%×0.93

= impliedABT realized, solidJNJ realized, hatchedOne scale, both sides: full bar = 11%× = |realized| ÷ impliedSource: market data

Q1 FY26

±3.0%

▲+0.90%

×0.30

Jan 21 '26±2.8%▼−0.09%×0.04

ABTAbbott Laboratories

110.28· pre 110.16· delayed

Mkt cap$183.8BRevenue$12.6BQ2 FY26Revenue$44.3BFY25

JNJJohnson & Johnson

271.04· pre 270.21· delayed

Pre-marketNov 3 '26delayed

Mkt cap$651.3BRevenue$25.4BQ3 FY26Revenue$94.2BFY25

Compare

Pre-marketNov 3 '26delayed

ABTAbbott Laboratories

JNJJohnson & Johnson

110.28pre 110.16delayed

Price

271.04pre 270.21delayed

$183.8B

Mkt cap

$651.3B

Q2 FY26$12.6B

Revenue

$25.4BQ3 FY26

FY25$44.3B

Revenue

$94.2BFY25

ABT110.28vsJNJ271.04Pre-marketNov 3 '26delayed